Prescription drug spending surges amid market forces Posted on March 29, 2016 by henrykotula Posted in Uncategorized Tagged ACA, Cancer Drugs, Chronic Hepatitis C, Compounded Medications, FDA, Generic Drugs, Hepatitis C Drugs, Medicaid Expansion, Non-Orphan Drugs, Orphan Drug Act, Orphan Drugs, PCSK9-inhibitors, Prescription Drug Spending, Specialty Medications, Ultra-Orphan Drugs Leave a comment http://managedhealthcareexecutive.modernmedicine.com/managed-healthcare-executive/news/prescription-drug-spending-surges-amid-market-forces?cfcache=true Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
New Push Ties Cost of Drugs to How Well They Work Posted on May 28, 2015 by henrykotula Posted in Uncategorized Tagged Alternative Pricing Models, Cancer Drugs, Indication-Specific Pricing Arrangements, Pay for Performance, Pharmaceutical, Pharmacy Benefit Management Leave a comment http://www.wsj.com/articles/new-push-ties-cost-of-drugs-to-how-well-they-work-1432684755 As drug costs rise, Express Scripts seeks new payment deals for some cancer medications Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
#JPM15: Ezekiel Emanuel talks health care costs – and why many cancer drugs just aren’t worth it Posted on January 14, 2015 by henrykotula Posted in Uncategorized Tagged Cancer Drugs, Healthcare, Healthcare Costs, Physician Incentives, Treatment Protocols Leave a comment #JPM15: Ezekiel Emanuel talks health care costs – and why many cancer drugs just aren’t worth it Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
More Medicine Goes Off Limits in Drug-Price Showdown Posted on December 1, 2014 by henrykotula Posted in Uncategorized Tagged Cancer Drugs, Drug Prices, Drug Pricing, Pharmaceutical Leave a comment http://www.bloomberg.com/news/2014-11-25/more-medicine-goes-off-limits-in-drug-price-showdown.html Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Major Medical Centers ask Congress to Probe Genentech Distribution Shift Posted on November 14, 2014 by henrykotula Posted in Uncategorized Tagged Cancer Drugs, Genentech, Supply Chain Leave a comment http://blogs.wsj.com/pharmalot/2014/11/11/major-medical-centers-ask-congress-to-probe-genentech-distribution-shift/tab/print/ Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
The cost of cancer drugs Posted on October 6, 2014 by henrykotula Posted in Uncategorized Tagged Cancer, Cancer Drugs, Healthcare Leave a comment http://www.cbsnews.com/news/the-cost-of-cancer-drugs/ http://www.cbsnews.com/60-minutes Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...